Arrowstreet Capital
CELL

Arrowstreet Capital’s PhenomeX Inc. Common Stock CELL Stock Holding History

Arrowstreet Capital’s Portfolio CELL Stock Details CELL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-4,171
Closed -$373K – 2620
2020
Q4 		$373K Buy
+4,171
New +$351K ﹤0.01% 2074

Other funds holding CELL

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
SUT
SC US (TTGP) Menlo Park, California $9.25B AUM 20.49% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FAM
Fred Alger Management New York $22.8B AUM 64.63% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Arrowstreet Capital's CELL Position: Q1 2021 in Review

Arrowstreet Capital sold out of PhenomeX Inc. Common Stock (CELL) in Q1 2021, closing a stake of 4,171 shares — an estimated $373K sold.

Arrowstreet Capital first reported a position in CELL in Q4 2020 and held it in 1 quarter. The position peaked at $373K in Q4 2020. 155 funds tracked by Wall St. Rank hold CELL as of Q1 2021.

  • Arrowstreet Capital reported no remaining PhenomeX Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Arrowstreet Capital sold 4,171 PhenomeX Inc. Common Stock shares in Q1 2021, an estimated $373K.
  • Arrowstreet Capital first reported a position in PhenomeX Inc. Common Stock in Q4 2020 and held it in 1 quarter.
  • Arrowstreet Capital's PhenomeX Inc. Common Stock position peaked at $373K in Q4 2020.
  • 155 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q1 2021.

Based on Arrowstreet Capital's 13F filing for Q1 2021, filed 14 May 2021.